87 related articles for article (PubMed ID: 37041423)
21. Therapeutic Strategies for RB1-Deficient Cancers: Intersecting Gene Regulation and Targeted Therapy.
Huang MF; Wang YX; Chou YT; Lee DF
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672640
[TBL] [Abstract][Full Text] [Related]
22. Advancements in the diagnosis, prognosis, and treatment of retinoblastoma.
Rajput S; Malviya R; Uniyal P
Can J Ophthalmol; 2024 Feb; ():. PubMed ID: 38369298
[TBL] [Abstract][Full Text] [Related]
23. miR-4529-3p Promotes the Progression of Retinoblastoma by Inhibiting RB1 Expression and Activating the ERK Signaling Pathway.
Gao Y; Du P
Mol Biotechnol; 2024 Jan; 66(1):102-111. PubMed ID: 37041423
[TBL] [Abstract][Full Text] [Related]
24. MiR-486-3p inhibits the proliferation, migration and invasion of retinoblastoma cells by targeting ECM1.
Yang H; Huang Y; He J; Chai G; Di Y; Wang A; Gui D
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32401301
[TBL] [Abstract][Full Text] [Related]
25. CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/β-catenin Signaling Pathway.
Fu C; Wang S; Jin L; Zhang M; Li M
Curr Eye Res; 2021 Jul; 46(7):978-987. PubMed ID: 33108919
[No Abstract] [Full Text] [Related]
26. Circular RNA has_circ_0000034 accelerates retinoblastoma advancement through the miR-361-3p/ADAM19 axis.
Jiang Y; Xiao F; Wang L; Wang T; Chen L
Mol Cell Biochem; 2021 Jan; 476(1):69-80. PubMed ID: 32844346
[TBL] [Abstract][Full Text] [Related]
27. Hsa_circ_0000527 Downregulation Suppresses the Development of Retinoblastoma by Modulating the miR-27a-3p/HDAC9 Pathway.
Zuo X; Fu C; Xie J; Wang X; Yan Z
Curr Eye Res; 2022 Jan; 47(1):115-126. PubMed ID: 34823425
[TBL] [Abstract][Full Text] [Related]
28. Dysregulation of miR-204-3p Driven by the Viability and Motility of Retinoblastoma via Wnt/β-catenin Pathway In Vitro and In Vivo.
Sun QX; Wang RR; Liu N; Liu C
Pathol Oncol Res; 2020 Jul; 26(3):1549-1558. PubMed ID: 31482398
[TBL] [Abstract][Full Text] [Related]
29. The miR-4306/IGF2R axis modulates the lung adenocarcinoma response to irradiation
Liu L; He L; Li W; Zhao T; Li G; Xiu X; Xu Y; Bourbonne V; Käsmann L; Kowalchuk RO; Zhong Q
Transl Lung Cancer Res; 2021 Dec; 10(12):4494-4510. PubMed ID: 35070756
[TBL] [Abstract][Full Text] [Related]
30. MiR-142-5p serves as a tumor suppressor in retinoblastoma cells by regulating MYCN.
Li H; Fan D; Wang W; Zhang X; Song L; Huang Y
Biochem Biophys Res Commun; 2021 Oct; 574():20-26. PubMed ID: 34425282
[TBL] [Abstract][Full Text] [Related]
31. Correlation between expression levels of lncRNA FER1L4 and RB1 in patients with colorectal cancer.
Ostovarpour M; Khalaj-Kondori M; Ghasemi T
Mol Biol Rep; 2021 May; 48(5):4581-4589. PubMed ID: 34132945
[TBL] [Abstract][Full Text] [Related]
32. miR-340 Promotes Retinoblastoma Cell Proliferation, Migration and Invasion Through Targeting WIF1.
Li K; Han F; Wu Y; Wang X
Onco Targets Ther; 2021; 14():3635-3648. PubMed ID: 34113129
[TBL] [Abstract][Full Text] [Related]
33. Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression.
Asl ER; Amini M; Najafi S; Mansoori B; Mokhtarzadeh A; Mohammadi A; Lotfinejad P; Bagheri M; Shirjang S; Lotfi Z; Rasmi Y; Baradaran B
Life Sci; 2021 Aug; 278():119499. PubMed ID: 33865878
[TBL] [Abstract][Full Text] [Related]
34. Clinical Utility of microRNAs in Exhaled Breath Condensate as Biomarkers for Lung Cancer.
Pérez-Sánchez C; Barbarroja N; Pantaleão LC; López-Sánchez LM; Ozanne SE; Jurado-Gámez B; Aranda E; Lopez-Pedrera C; Rodríguez-Ariza A
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33572343
[TBL] [Abstract][Full Text] [Related]
35. MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1.
Liu XM; Li XF; Li JC
Kaohsiung J Med Sci; 2021 Apr; 37(4):286-293. PubMed ID: 33340248
[TBL] [Abstract][Full Text] [Related]
36. Effect of miR-215 on the Expression of Tumor Suppressor Gene Rb1 in Retinoblastoma Cell Lines.
Shao L; Sheng Z; Zhu Y; Li J; Meng R
Iran J Public Health; 2020 Jul; 49(7):1298-1306. PubMed ID: 33083296
[TBL] [Abstract][Full Text] [Related]
37. MiR-218-5p Suppresses the Progression of Retinoblastoma Through Targeting NACC1 and Inhibiting the AKT/mTOR Signaling Pathway.
Li L; Yu H; Ren Q
Cancer Manag Res; 2020; 12():6959-6967. PubMed ID: 32821163
[TBL] [Abstract][Full Text] [Related]
38. miR-494 promotes progression of retinoblastoma via PTEN through PI3K/AKT signaling pathway.
Xu F; Liu G; Wang L; Wang X; Jin X; Bo W
Oncol Lett; 2020 Aug; 20(2):1952-1960. PubMed ID: 32724440
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
